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colonisation in children with cystic ﬁbrosis (CF): strains evolution
and clinical outcome correlations
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Evolution (2003–2007) of SA population in our CF centres with clinical correla-
tions.
Methods: 34 patients: 58.8% were male (n = 20), mean age: 15.8 (range 2 to
39 years), 76.5% (n = 26) pancreatic insufﬁcient, 5.9% (n = 2) diabetes, 88.2%
(n = 30) severe CFTR genotype; SA positive patients were deﬁned by at least three
consecutive positive SA sputum.
– Antimicrobial testing: disc diffusion
– MRSA strains were typed by pulsed ﬁeld gel electrophoresis and investigated for
Panton-Valentine leucocidine.
Results and Discussion: Strains analysis: A total of 90 strains were obtained from
22 patients (13 patients harboured more than two), 26.5% (n = 9) were colonized
with Pseudomonas aeruginosa (P.A.), 61.8% (n = 21) with MSSA, 5.9% (n = 2)
exclusively with MRSA, 5.9% (n = 2) were ﬁrstly colonised with MMSA and
secondarily with MRSA; 2.9% (n = 1) harboured both MMSA and MRSA strains.
Bacteriological resistance: 20 strains were resistant to more than 3 other antibiotic
families. No clonal relationship and no Panton–Valentine leucocidine could be
observed in MRSA population.
Clinical outcome correlations: Mean FEVI was 65.6% in 2007; mean actual loss in
FEV1 over 6 years of age was −3.3% per year (2005–2007) and −8.1% for MRSA
patients.
Conclusions:
– Prevalence of MRSA is 14.8% in our population with no phylogenic link.
– Impact on FEVI loss is signiﬁcantly higher with MRSA colonisation.
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Background: Methicillin-resistant Staphylococcus aureus (MRSA) has a well
recognized pathogenic role in cystic ﬁbrosis (CF).
Aims: To evaluate the prevalence and incidence of MRSA colonization, risk factors,
clinical impact of MRSA infection (year after ﬁrst MRSA isolation or after chronic
colonization if previously intermittent) and pattern of antimicrobial resistance.
Methods: Retrospective review of MRSA-positive CF patients during a ﬁve-year
period (2003–2007).
Results: Twelve (8 female; mean age 12 years 4 months) of the 60 patients followed
during this period were MRSA-positive at some time (chronic colonization in 3
patients). Mean age at acquisition was 9 years 10 months and at this time several
patients were chronically colonized with other respiratory pathogens, namely S
aureus (MSSA) in 6 patients.
An important rise in MRSA colonization prevalence and incidence was observed
during the study period (max. of 14.3% and 8.9%, respectively, in 2007).
Four of the 12 patients had received anti-staphylococcal prophylaxis with ﬂu-
cloxacillin.
An increase in the total number of in-patient days was observed in 4 patients
(2 chronically colonized). Deterioration in lung function was seen in 5 patients
(including the 3 patients with chronic colonization). Only one patient (intermittent
colonization) had a decrease in BMI percentile.
All isolates were susceptible to vancomycin and resistances to clindamycin and
rifampin were the most frequently seen.
Conclusions: This study revealed pulmonary clinical deterioration in patients with
chronic MRSA infection, reinforcing the importance of effective decolonization
strategies.
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Introduction: S. aureus is one of the ﬁrst bacteria to be isolated in CF. Infection
is normally symptomatic and chronic colonisation is common. In young children
prophylactic antistaphylococcal treatment reduces the frequency of S. aureus isolates
and decreases the number of antibiotic courses and hospital admissions. There is
no evidence to state whether continued antistaphylococcal treatment is beneﬁcial in
adult patients[1].
Aims: (1) To document the rates of S. aureus isolation in adult CF patients;
(2) to document the rates of antistaphylococcal prophylaxis and (3) to determine if
prophylactic antibiotics reduced S. aureus colonisation.
Methods: All patients at MACFC were studied over 12 months of 2005. Micro-
biology results were reviewed on the database. Antistaphylococcal antibiotic usage
was determined from patient records.
Results: 250/261 patients had >1 sputum sample in 12 months. S. aureus was
isolated in 61/250 patients (24.4%). In 15/250 (6%) S. aureus was the only isolate
and in 46/250 (18.4%) both S. aureus and P. aeruginosa were isolated. 83.6%
(209/250) of patients received antistaphylococcal antibiotics, 13.2% ﬂucloxacillin
alone, 27.2% azithromycin alone and 43.2% both. No difference was seen in rate of
isolation of S. aureus in those receiving azithromycin alone (19.1%), ﬂucloxacillin
with azithromycin (19.4%) and no antibiotics (22%) but was signiﬁcantly higher in
those on ﬂucloxacillin alone (54.5%) (p< 0.0001). Only 4/250 were colonised with
MRSA.
Conclusions: Isolation with S. aureus is common in adult patients with CF.
Flucloxacillin prophylaxis did not reduce rates of S. aureus isolation in this adult
population. We now offer patients the opportunity to stop long term ﬂucloxacillin.
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Background: The pathogenic role, need for treatment, and implications for noso-
comial spread of respiratory tract colonization with Sm in patients with CF are
controversial.
Methods: We conducted a retrospective study in CF patients <16 years of age,
who were colonized at least once with Sm. Individual episodes of colonization
were deﬁned as being separated by at least 12 months and 3 Sm negative cultures.
Results: Fifty-two patients were included. The mean age at ﬁrst recovery of Sm
and the duration of follow-up were 6.2±4.3 and 5.0±4.5 years, respectively. In
a Kaplan–Meier analysis, the proportion of Sm-free patients decreased linearly
between birth and 16 years of age. Seventeen patients (33%) were colonized only
once. These patients had a similar age (5.7 vs. 6.1 years, p = 0.83) compared to
patients with repetitive Sm positive cultures (3.9 vs. 6.7 years, p = 0.08). Once-
only colonization was associated with less frequent use of antibiotics during the 6
months preceding the ﬁrst recovery of Sm (5/17 vs. 24/35 patients; risk ratio 0.46;
95%CI 0.25−0.83). The frequency of resistance to cotrimoxazole (TMP-SMX) (0
vs. 4 patients, NS) and the use of TMP-SMX following the ﬁrst recovery of Sm (7
vs. 14 patients, NS) were similar. Nineteen patients (37%) had one episode of Sm
colonization with greater than 1 consecutive positive cultures (mean duration, 0.9
years), 16 patients had multiple episodes (31%). TMP-SMX resistance occurred in
4 patients (8%).
Conclusions: Acquisition of Sm occurred at a constant rate over the ﬁrst 16 years
of life. One third of patients were Sm positive only once. The use of TMP-SMX
did not appear to inﬂuence the frequency of Sm recovery despite that fact that most
isolates were sensitive to this agent in vitro.
